top of page

Email: contact@panakeia.ai

Search

London’s Best Health Diagnostics Companies

Apr 18, 2021
1 min read

Panakeia was picked for exception performance in innvation. See more

Panakeia to attend and present at upcoming scientific and business conferences

Cambridge, UK, 9 April 2025 – Panakeia (“the Company”), a pioneer in AI-enabled multi-omic biomarker profiling, is pleased to confirm...

Panakeia to present results of blinded multi-site validation of its AI-driven molecular profiling tool for colon cancer, PANProfiler Colon, at ASCO GI Symposium

Panakeia to present results of blinded multi-site validation of its AI-driven molecular profiling tool for colon cancer, PANProfiler Colon, at ASCO GI Symposium

Panakeia launches PANProfiler Colon, an AI-driven tool for precision medicine in colon cancer

PANProfiler Colon determines MSI/dMMR status in minutes from colon cancer tissue samples Entirely digital, AI-driven molecular profiling...

bottom of page